Literature DB >> 18771567

Subcutaneous lipoatrophy induced by long-term pegvisomant administration.

Cannavo Salvatore, Romanello Giovanni, Cavallari Vittorio, Scisca Claudio, Cannavo Serafinella Patrizia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18771567     DOI： 10.1111/j.1365-2265.2008.03400.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  3 in total

1.  Does pegvisomant treatment expertise improve control of resistant acromegaly? The Italian ACROSTUDY experience.

Authors:  S Cannavo; F Bogazzi; A Colao; L De Marinis; P Maffei; R Gomez; E Graziano; M Monterubbianesi; S Grottoli
Journal:  J Endocrinol Invest       Date:  2015-04-28       Impact factor: 4.256

Review 2.  Lipodystrophy during pegvisomant therapy: a case report and review of the literature.

Authors:  D Buyuktas; O Celik; F Kantarci; P Kadioglu
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

Review 3.  Pegvisomant in acromegaly: an update.

Authors:  A Giustina; G Arnaldi; F Bogazzi; S Cannavò; A Colao; L De Marinis; E De Menis; E Degli Uberti; F Giorgino; S Grottoli; A G Lania; P Maffei; R Pivonello; E Ghigo
Journal:  J Endocrinol Invest       Date:  2017-02-07       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.